Zora Rogers, M.D.

• Characterization of the natural history and improvement of the treatment of children and adolescents with non-malignant hematologic diseases such as congenital bone marrow failure syndromes, aplastic anemia thalassemia, sickle cell disease, and immune cytopenias
• Development of optimum management approaches to major clinical events in children with sickle cell disease (febrile illness, chest syndrome, painful crisis, avascular necrosis, stroke)
• Use of hydroxyurea, transfusion, stem cell transplantation and other therapies, particularly in young children, to prevent the morbidity of sickle cell anemia

 Featured Books

 Bone marrow failure syndromes. In Werner E, de Alarcon P, Christensen RD, eds. Neonatal Hematology: Pathogenesis, Diagnosis, and Management of Hematologic Problems. 2nd ed.

Rogers ZR, Alter BP. (2013). Cambridge University Press; 47-64.

 Anemia Due to Diminished Red Blood Cell Production. In Rudolph CD, Rudolph AM, Lister G, First LR, Gershon AA, eds. Rudolph's Pediatrics. 22nd ed.

Rogers ZR. (2011). McGraw-Hill; 1549-1551.

 Chediak-Higashi syndrome. In Roach ES, Miller VS, eds. Neurocutaneous Disorders.

Farah RA, Rogers ZR. (2004). Cambridge University Press; 296-300.

• Best Pediatric Specialists in Dallas
  D Magazine (2015-2017)
• Mom-Approved Doctor
  Child Magazine (2015)
• Physician Scientist Award, Fellow
  Damon Runyon-Walter Winchell Cancer Research Fund (1990-1993)
• American Cancer Society
  Texas Division Oncology, Research Fellowship (1989)
• Phi Beta Kappa
  Alpha of California (1978)

• American Academy of Pediatrics (1987)
• American Pediatric Society
• American Society of Hematology (1990)
• American Society of Pediatric Hematology/Oncology (1989)
• Society for Pediatric Research